Merck & Co., Inc.
MRK· NYSE
Merck & Co., Inc.
- Last sale
- Oct 1, 2026 · -1.16%
- Market cap
- $354.69B
- 2.47B shares
- Filings
- 1,064
Price
Oct 1, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $65,011,000,000 | reported | |
| FY 2024 | 2024-12-31 | $64,168,000,000 | reported | |
| FY 2023 | 2023-12-31 | $60,115,000,000 | reported | |
| FY 2022 | 2022-12-31 | $59,283,000,000 | reported | |
| FY 2021 | 2021-12-31 | $48,704,000,000 | reported | |
| FY 2020 | 2020-12-31 | $41,518,000,000 revised | reported | |
| FY 2019 | 2019-12-31 | $39,121,000,000 revised | reported | |
| FY 2018 | 2018-12-31 | $42,294,000,000 | reported | |
| FY 2017 | 2017-12-31 | $40,122,000,000 | reported | |
| FY 2016 | 2016-12-31 | $39,807,000,000 | reported | |
| FY 2010 | 2010-12-31 | $45,987,000,000 | reported | |
| FY 2009 | 2009-12-31 | $27,428,000,000 | reported |
Merck & Co., Inc. · CIK 310158 · Engraved from SEC EDGAR
